The Formulation Design & Development Section is comprised of members from many diverse backgrounds in industry, regulatory and academia who share a common interest in the area of formulation design, research and development - a multidisciplinary field drawing upon the physical, chemical, biological and engineering sciences. The primary goal of this section is to unite multiple scientific disciplines in a forum where they can share experimental results, consider new formulation and dosage form technologies, and discuss issues and concerns regarding the design and development of formulations/drug products for all dosage forms. This Section collaboratively interfaces with other sections which focus on pre-formulation, biopharmaceutics, formulation strategies, and manufacturing process optimization.

Aspects of formulation design and development include the study of dosage forms for drug delivery via all routes of administration wherein the dosage form encompasses the formulation, process by which it is made, and primary packaging. The Section’s focus on development includes product design, delivery systems and technology, stability, quality, and performance both in vitro and in vivo that is appropriate to its development stage.

Section Vision

The Formulation Design and Development Section will be the premier worldwide forum for scientists dedicated to the design and development of all dosage forms.

Section Mission

The Formulation Design and Development Section provides a dynamic international forum for the exchange of formulation-related knowledge among scientists to enhance their contributions to health. We offer timely formulation-related scientific programs, on-going education, opportunities for networking, and professional development by:

• Providing forums for the free interchange and dissemination of scientific knowledge, particularly in the area of formulation design and development;
• Fostering the scientific and technical growth of scientists in the discipline;
• Promoting and recognizing excellence in the discipline;
• Encouraging the support of basic academic, industrial, and regulatory research programs and the development of mutually beneficial relationships;
• Encouraging students to enter the discipline by strengthening and increasing the viability of academic programs in formulation design and development;
• Collaborating with and supporting other AAPS sections, focus groups, and other professional/scientific organizations; and
• Informing the public of major advances in formulation design and development.

FIP Pharmaceutical Sciences World Congress 2010 in association with the AAPS Annual Meeting & Exposition

FDD Programming

Program-at-a-Glance

Meeting Website

Meeting Registration
Registration rates increase after September 10, 2010.

Housing Reservations
Hotel Reservation Deadline: October 22, 2010

Volunteer for the FDD Section Booth (Coming Soon)

Formulation Design and Development Headlines

FDA Puts Brakes on Roche, ImmunoGen Cancer Drug
Reuters (08/27/10) de Sa'Pinto, Martin; Reid, Katie

AAPS Announces Results of 2010 Election
AAPS Press Release (08/24/2010)

Orphan Drug Research Suddenly in Vogue
eCliniqua (08/16/10) Borfitz, Deb

Molecular Bandit Keeps Pain at Bay
Newswise (08/02/10)

Robot Pills
Scientific American (08/10) Vol. 303, No. 2, P. 62; Dario, Paolo; Menciassi, Arianna

Human Clinical Trial of NIH-Developed Dengue Vaccine Begins
NIH News Release (08/09/10)

Adipose Stem Cell Developments Overseas Open New Doors for Cosmetic Surgery
Modern Medicine (08/01/10) Nataloni, Rochelle

Meeting Highlights From the Committee for Medicinal Products for Human Use (CHMP)
European Medicines Agency (07/23/2010)

Nano-Patch to Replace Needles for Vaccination Soon: Study
News-Medical.Net (07/26/2010) Mandal, Ananya

Multifunctional Nanoparticles as Coupled Contrast Agents
Nature Communications (07/27/10) Jun, Yongdong; Jia, Congxian; Huang, Sheng-Wen; et al.

Dissolving Polymer Microneedle Patches for Influenza Vaccination
Nature Medicine (07/10) Sullivan, Sean P.; Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; et al.

Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health...
NIH News Release (07/20/10)

Should Birth-Control Pill Be Sold Without a Prescription?
Newsweek (07/07/10) Melnick, Meredith

Crucell Starts Work on RSV Vaccine
Reuters (06/24/10) Gay-Block, Aaron

Botox May Affect Ability to Feel Emotions
WebMD (06/23/10) Mann, Denise

Tremendously Successful AAPS Webinar Series on ADME and Pharmacokinetics in Drug Discovery/Development to Present Third Installment
AAPS Press Release (06/29/2010)

Stem Cells Used to Create Cells to Study Heart Condition
National Institutes of Health - Research Matters (06/21/2010) Wein, Harrison

FDA Wants More Info on GlaxoSmithKline Vaccine MenHibrix
Triangle Business Journal (06/14/10) Gallagher, James